title: Interferon alfa-2a tretinoin in patients with metastatic renal cell carcinoma: a pilot study.
authors.affiliation: Service of Blood Disorders and Tumors, Hôpital Paul Brousse, Villejuif, France.
authors.forename: B
authors.initials: B
authors.lastname: Paule
authors.forename: L
authors.initials: L
authors.lastname: Bonhomme-Faivre
authors.forename: E
authors.initials: E
authors.lastname: Rudant
authors.forename: F
authors.initials: F
authors.lastname: Ferrière
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011994:Recombinant Proteins; D015996:Survival Rate; D014212:Tretinoin / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014212:Tretinoin